Odomzo (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Odomzo drug offered from Novartis Pharmaceuticals Corporation. This Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | sonidegib |
| SUBSTANCE NAME: | SONIDEGIB PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-07-24 |
| END MARKETING DATE: | 2017-12-31 |
Odomzo HUMAN PRESCRIPTION DRUG Details:
| Item Description | Odomzo from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2015-07-24 |
| END MARKETING DATE: | 2017-12-31 |
| PRODUCT ID: | 0078-0645_33db8080-93db-4c75-91ad-d5b96b4c7b41 |
| PRODUCT NDC: | 0078-0645 |
| APPLICATION NUMBER: | NDA205266 |
Other SONIDEGIB PHOSPHATE Pharmaceutical Manufacturers / Labelers:
